The estimated Net Worth of Asher Holzer is at least $2.55 Million dollars as of 26 November 2013. Asher Holzer owns over 597,300 units of Biosig Technologies Inc stock worth over $862,449 and over the last 12 years Asher sold BSGM stock worth over $1,684,069.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Asher Holzer BSGM stock SEC Form 4 insiders trading
Asher has made over 4 trades of the Biosig Technologies Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Asher sold 597,300 units of BSGM stock worth $1,576,872 on 26 November 2013.
The largest trade Asher's ever made was selling 597,300 units of Biosig Technologies Inc stock on 26 November 2013 worth over $1,576,872. On average, Asher trades about 108,333 units every 36 days since 2013. As of 26 November 2013 Asher still owns at least 1,925,110 units of Biosig Technologies Inc stock.
You can see the complete history of Asher Holzer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Asher Holzer's mailing address?
Asher's mailing address filed with the SEC is 3 MENORAT HAMAOR ST, , TEL AVIV, L3, 67448.
Insiders trading at Biosig Technologies Inc
Over the last 9 years, insiders at Biosig Technologies Inc have traded over $1,778,587 worth of Biosig Technologies Inc stock and bought 1,345,515 units worth $2,296,289 . The most active insiders traders include Kenneth L Londoner, Asher Holzer, and Jerome B Zeldis. On average, Biosig Technologies Inc executives and independent directors trade stock every 24 days with the average trade being worth of $11,433. The most recent stock trade was executed by Kenneth L Londoner on 13 June 2023, trading 15,600 units of BSGM stock currently worth $19,344.
What does Biosig Technologies Inc do?
biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.
What does Biosig Technologies Inc's logo look like?
Complete history of Asher Holzer stock trades at InspireMD Inc and Biosig Technologies Inc
Biosig Technologies Inc executives and stock owners
Biosig Technologies Inc executives and other stock owners filed with the SEC include:
-
Kenneth Londoner,
Executive Chairman of the Board, Chief Executive Officer -
Steven Chaussy,
Chief Financial Officer -
Kenneth L. Londoner M.B.A., MBA,
Founder, CEO & Exec. Chairman -
Samuel Navarro,
Independent Director -
Jeffrey O'Donnell,
Lead Independent Director -
Martha Pease,
Independent Director -
Andrew Filler,
Independent Director -
David Weild,
Independent Director -
Patrick Gallagher,
Independent Director -
Donald Foley,
Independent Director -
Anthony Zook,
Director -
Manasi Patwardhan,
Director of Strategic Planning -
Olivier Chaudoir,
Senior Director of Marketing -
Julie Stephenson,
Vice President - Clinical Affairs, Senior Director of Clinical Affairs -
Andrew Ballou,
Vice President - Investor Relations -
John Kowalski,
Vice President - Sales -
John Sieckhaus,
Chief Operating Officer -
Gray Fleming,
Chief Commercial Officer -
Steven Chaussy,
Chief Financial Officer -
Natasha Drapeau,
Exec. VP -
Brenda Castrodad,
Director of HR -
Lora Mikolaitis,
VP of Admin. -
Dr. Budimir S. Drakulic Ph.D.,
Chief Scientist -
Steven Eric Abelman,
Director -
Steve Chaussy,
Chief Financial Officer -
Roy T Tanaka,
Director -
Lora Mikolaitis,
10% owner -
Seth H. Z. Fischer,
Director -
Joseph Rafferty,
Chief Commercialization Offcr -
Jerome B Zeldis,
Director -
Asher Holzer,
Director -
Gregory D Cash,
President and CEO -
James L Klein,
Director -
James J Barry,
Director -
John Sieckhaus,
Chief Operating Officer -
Gray Fleming,
Chief Commercial Officer -
Steven J Buhaly,
Chief Financial Officer -
Frederick Hrkac,
Director -
Donald Browne,
Director -
Christopher Allen Baer,
Director